Literature DB >> 17462597

Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells.

Yong Gil Kim1, Chang-Keun Lee, Seong-Su Nah, Se Hwan Mun, Bin Yoo, Hee-Bom Moon.   

Abstract

Regulatory T cell (Treg) is a subset of CD4+ T lymphocytes expressing CD25 with immunosuppressive activity. However the function of Tregs onto osteoclastogenesis remains unknown. We investigated the effect and regulatory mechanism of Treg focusing on osteoclastogenesis from PBMCs. Tregs were isolated from PBMCs by magnetic cell sorting-column and analyzed by flow cytometry. RT-PCR was performed to identify Foxp3 mRNA. Using PBMCs and Tregs coculture system, we could find that Tregs inhibited osteoclasts differentiation from PBMCs and reduced the resorbed areas on pit assay (p <0.01). This suppression of osteoclast differentiation was cytokine-dependent, not cell-to-cell direct contact proved by Transwell system. Tregs-induced osteoclast differentiation was blocked by anti-TGF-beta or anti-IL-4 antibody treatment. These results suggest that Tregs inhibit osteoclast differentiation from PBMCs in a cytokine-dependent manner, not by cell-to-cell contact manner and that TGF-beta and IL-4 may be the key cytokines for this suppressive function of Tregs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462597     DOI: 10.1016/j.bbrc.2007.04.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  67 in total

Review 1.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

2.  Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.

Authors:  Dallas Jones; Laurie H Glimcher; Antonios O Aliprantis
Journal:  J Clin Invest       Date:  2011-07-01       Impact factor: 14.808

Review 3.  T Regulatory Cells in Bone Remodelling.

Authors:  Aline Bozec; Mario M Zaiss
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 4.  Intercellular cross-talk among bone cells: new factors and pathways.

Authors:  Natalie A Sims; Nicole C Walsh
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

Review 5.  The immune system and bone.

Authors:  Roberto Pacifici
Journal:  Arch Biochem Biophys       Date:  2010-06-17       Impact factor: 4.013

6.  Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro.

Authors:  C Y Luo; L Wang; C Sun; D J Li
Journal:  Cell Mol Immunol       Date:  2010-12-06       Impact factor: 11.530

7.  From the gut to the strut: where inflammation reigns, bone abstains.

Authors:  Jameel Iqbal; Tony Yuen; Li Sun; Mone Zaidi
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

Review 8.  Bone Remodeling and the Microbiome.

Authors:  Roberto Pacifici
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

9.  The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

Authors:  Kritika Kachapati; David E Adams; Yuehong Wu; Charles A Steward; Daniel B Rainbow; Linda S Wicker; Robert S Mittler; William M Ridgway
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

Review 10.  Current understanding of osteoporosis associated with liver disease.

Authors:  Inaam A Nakchbandi; Schalk W van der Merwe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.